ARRHYTHMOGENIC LEFT VENTRICULAR CARDIOMYOPATHY
Clinical trials for ARRHYTHMOGENIC LEFT VENTRICULAR CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new ARRHYTHMOGENIC LEFT VENTRICULAR CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for ARRHYTHMOGENIC LEFT VENTRICULAR CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart rhythm battle: zapping vs. pills for Life-Threatening condition
Disease control OngoingThis study compares two approaches for controlling dangerous rapid heart rhythms (ventricular tachycardia) in people with weakened heart muscles. Researchers are testing whether a procedure called catheter ablation (using heat or cold to destroy small areas of heart tissue causin…
Matched conditions: ARRHYTHMOGENIC LEFT VENTRICULAR CARDIOMYOPATHY
Phase: NA • Sponsor: Western Sydney Local Health District • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Experimental drug targets deadly heart rhythm disorder
Disease control TerminatedThis early-stage study is testing whether an experimental drug called IC14 can help control arrhythmogenic cardiomyopathy, a serious heart condition that causes dangerous irregular heartbeats. Five patients who already have implanted defibrillators will receive four intravenous i…
Matched conditions: ARRHYTHMOGENIC LEFT VENTRICULAR CARDIOMYOPATHY
Phase: PHASE1, PHASE2 • Sponsor: Implicit Bioscience • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC